-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Dianthus Therapeutics, Raises Price Target to $81

Benzinga·02/02/2026 20:54:23
Listen to the news
Jefferies analyst Maury Raycroft maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Buy and raises the price target from $66 to $81.